References
- Michalek IM, Loring B, John SM. A systematic review of worldwide epidemiology of psoriasis. J Eur Acad Dermatol Venereol. 2017;31(2):205–212. doi:10.1111/jdv.13854.
- Ghalamkarpour F, Baradaran-Rafii A, Sadoughi MM, et al. Ocular findings in patients with psoriasis: is it related to the side effects of treatment or to psoriasis itself? A case-control study. J Dermatolog Treat. 2020;31(1):27–32. doi:10.1080/09546634.2019.1577947.
- Abbouda A, Abicca I, Fabiani C, et al. Psoriasis and psoriatic arthritis-related uveitis: different ophthalmological manifestations and ocular inflammation features. Semin Ophthalmol. 2017;32(6):715–720. doi:10.3109/08820538.2016.1170161.
- Rehal B, Modjtahedi BS, Morse LS, Schwab IR, Maibach HI. Ocular psoriasis. J Am Acad Dermatol. 2011;65(6):1202–1212. doi:10.1016/j.jaad.2010.10.032.
- Fotidau C, Lazaridou E. Psoriasis and uveitis: links and risks. Psoriasis Targets Therapy. 2019;9:91–96.
- Ozek D, Onen M, Karaca EE, et al. The optical coherence tomography angiography findings of rheumatoid arthritis patients taking hydroxychloroquine. Eur J Ophthalmol. 2019;29(5):532–537. doi:10.1177/1120672118801125.
- Schmitt J, Wozel G. The psoriasis area and severity index is the adequate criterion to define severity in chronic plaque-type psoriasis. Dermatology. 2005;210(3):194–199.
- Pichi F, Woodstock E, Hay S, Neri P. Optical coherence tomography angiography findings in systemic lupus erythematosus patients with no ocular disease. Int Ophthalmol. 2020;40:2111–2118. doi:10.1007/s10792-020-01388-3.
- Alkan AA, Uslu Dogan C, Turker IC. Optical coherence tomography angiography for evaluation of retinal vascular changes in patients with psoriasis according to disease severity. Ocul Immunol Inflamm. 2022;30(2):433–438. doi:10.1080/09273948.2020.1817496.
- Castellino N, Longo A, Fallico M, et al. Retinal vascular assessment in psoriasis: a multicenter study. Front Neurosci. 2021;15:629401. doi:10.3389/fnins.2021.629401.
- Keles Sahin A, Etgu F, Uzun A. Assessment of central retinal thickness, choroidal thickness, and retinal nerve fiber layer in psoriasis: a spectral-domain optical coherence tomography study. BMC Ophthalmol. 2021;21:233. doi:10.1186/s12886-021-02000-7.
- Ersan I, Kilic S, Arikan S, et al. Evaluation of macular ganglion cell-inner plexiform layer and choroid in psoriasis patients using enhanced depth imaging spectral domain optical coherence tomography. Ocul Immunol Inflamm. 2017;25(4):520–524. doi:10.3109/09273948.2016.1150493.
- Aksoy M, Toptan M, An I. Retinal nerve fibre layer thickness and choroidal thickness: an evaluation in psoriasis patients. Int J Clin Pract. 2020;8:e13904.
- Türkcü FM, Sahin A, Yüksel H, et al. Evaluation of choroidal thickness in psoriasis using optical coherence tomography. Int Ophthalmol. 2016;36(6):851–854. doi:10.1007/s10792-016-0212-9.
- Kılıc R, Kurt A, Acer E, et al. Choroidal thickness in psoriasis. Int Ophthalmol. 2017;37(1):173–177. doi:10.1007/s10792-016-0252-1.
- Paiva ES, Macaluso DC, Edwards A. Characterization of uveitis in patients with psoriatic arthritis. Ann Rheum Dis. 2000;59:67–70. doi:10.1136/ard.59.1.67.
- Fraga NA, Oliveira Mde F, Follador I, and Rêgo VR. Psoriasis and uveitis: a literature review. Ann Bras Dermatol. 2012;87:877–883. doi:10.1590/S0365-05962012000600009.
- Chandran NS, Greaves M, Gao F, and Cheng BCL. Psoriasis and the eye: prevalence of eye disease in Singaporean Asian patients with psoriasis. J Dermatol. 2007;34:805–810. doi:10.1111/j.1346-8138.2007.00390.x.
- Egeberg A, Khalid U, Gislason GH, Skov L, and Hansen PR. Association of psoriatic disease with uveitis: a Danish nationwide cohort study. JAMA Dermatol. 2015;151:1200–1205. doi:10.1001/jamadermatol.2015.1986.